Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for High-Intermediate and High-Risk Endometrial Cancer: A Prospective Multicenter Phase II Safety Cohort Study

NCT07779109 is registered in ClinicalTrials.gov with Instituto de Investigación Sanitaria Aragón as lead sponsor.

NCT NCT07779109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07779109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for High-Intermediate and High-Risk Endometrial Cancer: A Prospective Multicenter Phase II Safety Cohort Study
Lead sponsor
Instituto de Investigación Sanitaria Aragón
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2026
Completion date
March 30, 2035
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, endometrial cancer stage iii, high-risk endometrial cancer, radiation therapy, sbrt